SEC Form 4 · accession 0001140361-17-034488
CYTRX CORP · CYTR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joel K Caldwell
Director
Period of report
Jul 12, 2017
Accepted (ET)
Sep 6, 2017 · 8:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000799698
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F1 | $0.67 | Jul 12, 2017 | A | 180,000 | A | Jul 12, 2017 | Jul 11, 2027 | CytRx Common Stock | 180,000 | 180,000 | D |
Explanation of responses
- F1This initial grant of stock options was made to Mr. Caldwell upon his joining the CytRx Board of Directors on July 12, 2017. His appointment to the board and the start date of his term was approved by the board at its meeting on May 5, 2017.